The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nagler, A.
Right arrow Articles by Phillips, J. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nagler, A.
Right arrow Articles by Phillips, J. H.

The Journal of Immunology, Vol 143, Issue 10 3183-3191, Copyright © 1989 by American Association of Immunologists

ARTICLES

Comparative studies of human FcRIII-positive and negative natural killer cells

A Nagler, LL Lanier, S Cwirla and JH Phillips
Becton Dickinson Monoclonal Center, Inc., Mountain View, CA 94043.

In the present study we have identified and characterized three subpopulations of peripheral blood NK cells based on the surface expression of CD56 and CD16. We have designated these subsets CD16neg, CD16dim, and CD16bright according to the relative surface density of CD16. The CD16bright subset comprised about 10% to 15% of PBL, whereas the CD16dim and CD16neg subsets comprise less than 1% of the total lymphocytes. A detailed characterization of these subsets revealed both similarities and differences. The three subsets shared a great deal of phenotypic similarity, expressing CD2, CD7, CD11b, CD38, CD45R, CD18, and the p75 IL-2R on the majority of the cells in each subset. There were, however, several prominent phenotypic differences, particularly in the expression of CD57, CD11c, CD44, CD25, Leu-8, L263, and L265. The CD16neg cells were morphologically large agranular lymphocytes and demonstrated low levels of non-MHC restricted cytolysis of NK-sensitive tumor lines. The CD16dim and CD16bright subsets were large granular lymphocytes and revealed potent cytotoxicity against NK-sensitive targets. All subsets demonstrated IL-2-dependent activation and proliferation; however, the CD16dim and CD16neg subsets were preferentially responsive to very low concentrations of rIL-2. Although rIL-4 effectively inhibited the IL-2-induced cytolytic activation of all three NK cell subsets, only the CD16bright cells showed rIL-4 inhibition of IL-2 dependent proliferation. Cytokine transcription was also differentially regulated in the NK cell subsets after rIL-2 activation. Although TNF-alpha was equally transcribed in each subsets, IFN-gamma and serine protease-HF were preferentially transcribed in the CD16bright NK cells. Based on these results, we propose that these NK cell subsets represent portions of the NK cell differentiation pathway present in the peripheral blood.


This article has been cited by other articles:


Home page
 J. Leukoc. Biol.Home page
Y.-C. Huang, S.-W. Hung, T.-R. Jan, K.-W. Liao, C.-H. Cheng, Y.-S. Wang, and R.-M. Chu
CD5-low expression lymphocytes in canine peripheral blood show characteristics of natural killer cells
J. Leukoc. Biol., December 1, 2008; 84(6): 1501 - 1510.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
I. Manaster, S. Mizrahi, D. Goldman-Wohl, H. Y. Sela, N. Stern-Ginossar, D. Lankry, R. Gruda, A. Hurwitz, Y. Bdolah, R. Haimov-Kochman, et al.
Endometrial NK Cells Are Special Immature Cells That Await Pregnancy
J. Immunol., August 1, 2008; 181(3): 1869 - 1876.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
A. Silva, D. M. Andrews, A. G. Brooks, M. J. Smyth, and Y. Hayakawa
Application of CD27 as a marker for distinguishing human NK cell subsets
Int. Immunol., April 1, 2008; 20(4): 625 - 630.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
H. Zhang and G. G. Meadows
Chronic alcohol consumption perturbs the balance between thymus-derived and bone marrow-derived natural killer cells in the spleen
J. Leukoc. Biol., January 1, 2008; 83(1): 41 - 47.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
T. Tha-In, H. J. Metselaar, H. W. Tilanus, Z. M. A. Groothuismink, E. J. Kuipers, R. A. de Man, and J. Kwekkeboom
Intravenous immunoglobulins suppress T-cell priming by modulating the bidirectional interaction between dendritic cells and natural killer cells
Blood, November 1, 2007; 110(9): 3253 - 3262.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
H. Harlin, M. Hanson, C. C. Johansson, D. Sakurai, I. Poschke, H. Norell, K.-J. Malmberg, and R. Kiessling
The CD16 CD56bright NK Cell Subset Is Resistant to Reactive Oxygen Species Produced by Activated Granulocytes and Has Higher Antioxidative Capacity Than the CD16+CD56dim Subset
J. Immunol., October 1, 2007; 179(7): 4513 - 4519.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
H. Wang, B. Grzywacz, D. Sukovich, V. McCullar, Q. Cao, A. B. Lee, B. R. Blazar, D. N. Cornfield, J. S. Miller, and M. R. Verneris
The unexpected effect of cyclosporin A on CD56+CD16 and CD56+CD16+ natural killer cell subpopulations
Blood, September 1, 2007; 110(5): 1530 - 1539.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
F. B. Thoren, A. I. Romero, S. Hermodsson, and K. Hellstrand
The CD16-/CD56bright Subset of NK Cells Is Resistant to Oxidant-Induced Cell Death
J. Immunol., July 15, 2007; 179(2): 781 - 785.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. Chan, D.-L. Hong, A. Atzberger, S. Kollnberger, A. D. Filer, C. D. Buckley, A. McMichael, T. Enver, and P. Bowness
CD56bright Human NK Cells Differentiate into CD56dim Cells: Role of Contact with Peripheral Fibroblasts
J. Immunol., July 1, 2007; 179(1): 89 - 94.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
O. Cohavy and S. R. Targan
CD56 Marks an Effector T Cell Subset in the Human Intestine
J. Immunol., May 1, 2007; 178(9): 5524 - 5532.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
K. Wendt, E. Wilk, S. Buyny, J. Buer, R. E. Schmidt, and R. Jacobs
Gene and protein characteristics reflect functional diversity of CD56dim and CD56bright NK cells
J. Leukoc. Biol., December 1, 2006; 80(6): 1529 - 1541.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
X.-S. He, T. H. Holmes, C. Zhang, K. Mahmood, G. W. Kemble, D. B. Lewis, C. L. Dekker, H. B. Greenberg, and A. M. Arvin
Cellular Immune Responses in Children and Adults Receiving Inactivated or Live Attenuated Influenza Vaccines
J. Virol., December 1, 2006; 80(23): 11756 - 11766.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
Y. Le Priol, D. Puthier, C. Lecureuil, C. Combadiere, P. Debre, C. Nguyen, and B. Combadiere
High Cytotoxic and Specific Migratory Potencies of Senescent CD8+CD57+ Cells in HIV-Infected and Uninfected Individuals
J. Immunol., October 15, 2006; 177(8): 5145 - 5154.
[Abstract] [Full Text] [PDF]

Home page
 Clin Med ResHome page
E. Mavoungou
Interactions between natural killer cells, cortisol and prolactin in malaria during pregnancy.
Clin. Med. Res., March 1, 2006; 4(1): 33 - 41.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. J. van den Heuvel, J. Horrocks, S. Bashar, S. Taylor, S. Burke, K. Hatta, J. E. Lewis, and B. A. Croy
Menstrual Cycle Hormones Induce Changes in Functional Interactions between Lymphocytes and Decidual Vascular Endothelial Cells
J. Clin. Endocrinol. Metab., May 1, 2005; 90(5): 2835 - 2842.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
Z. Li, W. K. Lim, S. P. Mahesh, B. Liu, and R. B. Nussenblatt
Cutting Edge: In Vivo Blockade of Human IL-2 Receptor Induces Expansion of CD56bright Regulatory NK Cells in Patients with Active Uveitis
J. Immunol., May 1, 2005; 174(9): 5187 - 5191.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
R. Niwa, M. Sakurada, Y. Kobayashi, A. Uehara, K. Matsushima, R. Ueda, K. Nakamura, and K. Shitara
Enhanced Natural Killer Cell Binding and Activation by Low-Fucose IgG1 Antibody Results in Potent Antibody-Dependent Cellular Cytotoxicity Induction at Lower Antigen Density
Clin. Cancer Res., March 15, 2005; 11(6): 2327 - 2336.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
C. Dosiou and L. C. Giudice
Natural Killer Cells in Pregnancy and Recurrent Pregnancy Loss: Endocrine and Immunologic Perspectives
Endocr. Rev., February 1, 2005; 26(1): 44 - 62.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
S. Li, J. Xu, V. P. Makarenkova, T. Tjandrawan, J. Vakkila, T. Reichert, W. Gooding, C. F. Lagenaur, C. L. Achim, W. H. Chambers, et al.
A novel epitope of N-CAM defines precursors of human adherent NK cells
J. Leukoc. Biol., December 1, 2004; 76(6): 1187 - 1199.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
N. Dalbeth, R. Gundle, R. J. O. Davies, Y. C. G. Lee, A. J. McMichael, and M. F. C. Callan
CD56bright NK Cells Are Enriched at Inflammatory Sites and Can Engage with Monocytes in a Reciprocal Program of Activation
J. Immunol., November 15, 2004; 173(10): 6418 - 6426.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
M. Eriksson, S. K. Meadows, C. R. Wira, and C. L. Sentman
Unique phenotype of human uterine NK cells and their regulation by endogenous TGF-{beta}
J. Leukoc. Biol., September 1, 2004; 76(3): 667 - 675.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
D. Pelloso, K. Cyran, L. Timmons, B. T. Williams, and M. J. Robertson
Immunological Consequences of Interleukin 12 Administration after Autologous Stem Cell Transplantation
Clin. Cancer Res., March 15, 2004; 10(6): 1935 - 1942.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. J. Loza and B. Perussia
The IL-12 Signature: NK Cell Terminal CD56+high Stage and Effector Functions
J. Immunol., January 1, 2004; 172(1): 88 - 96.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
K. Kitaya, T. Nakayama, T. Okubo, H. Kuroboshi, S. Fushiki, and H. Honjo
Expression of Macrophage Inflammatory Protein-1{beta} in Human Endometrium: Its Role in Endometrial Recruitment of Natural Killer Cells
J. Clin. Endocrinol. Metab., April 1, 2003; 88(4): 1809 - 1814.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
D. Voehringer, M. Koschella, and H. Pircher
Lack of proliferative capacity of human effector and memory T cells expressing killer cell lectinlike receptor G1 (KLRG1)
Blood, November 15, 2002; 100(10): 3698 - 3702.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
S. S. Farag, T. A. Fehniger, L. Ruggeri, A. Velardi, and M. A. Caligiuri
Natural killer cell receptors: new biology and insights into the graft-versus-leukemia effect
Blood, August 28, 2002; 100(6): 1935 - 1947.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
M. Vitale, J. Zimmer, R. Castriconi, D. Hanau, L. Donato, C. Bottino, L. Moretta, H. de la Salle, and A. Moretta
Analysis of natural killer cells in TAP2-deficient patients: expression of functional triggering receptors and evidence for the existence of inhibitory receptor(s) that prevent lysis of normal autologous cells
Blood, March 1, 2002; 99(5): 1723 - 1729.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
M. J. Robertson
Role of chemokines in the biology of natural killer cells
J. Leukoc. Biol., February 1, 2002; 71(2): 173 - 183.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. Dunne, S. Lynch, C. O'Farrelly, S. Todryk, J. E. Hegarty, C. Feighery, and D. G. Doherty
Selective Expansion and Partial Activation of Human NK Cells and NK Receptor-Positive T Cells by IL-2 and IL-15
J. Immunol., September 15, 2001; 167(6): 3129 - 3138.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
K. Ogawa, K. Tanaka, A. Ishii, Y. Nakamura, S. Kondo, K. Sugamura, S. Takano, M. Nakamura, and K. Nagata
A Novel Serum Protein That Is Selectively Produced by Cytotoxic Lymphocytes
J. Immunol., May 15, 2001; 166(10): 6404 - 6412.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
M. A. Cooper, T. A. Fehniger, S. C. Turner, K. S. Chen, B. A. Ghaheri, T. Ghayur, W. E. Carson, and M. A. Caligiuri
Human natural killer cells: a unique innate immunoregulatory role for the CD56bright subset
Blood, May 15, 2001; 97(10): 3146 - 3151.
[Abstract] [Full Text] [PDF]

Home page
 Ann Rheum DisHome page
T Kogure, A Niizawa, L X Hai, H Fujinaga, Y Shimada, H Ochiai, and K Terasawa
Effect of interleukin 2 on killer cell inhibitory receptors in patients with rheumatoid arthritis
Ann Rheum Dis, February 1, 2001; 60(2): 166 - 169.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
G. Nicoll, J. Ni, D. Liu, P. Klenerman, J. Munday, S. Dubock, M.-G. Mattei, and P. R. Crocker
Identification and Characterization of a Novel Siglec, Siglec-7, Expressed by Human Natural Killer Cells and Monocytes
J. Biol. Chem., November 26, 1999; 274(48): 34089 - 34095.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. Galea-Lauri, D. Darling, S.-U. Gan, L. Krivochtchapov, M. Kuiper, J. Gaken, B. Souberbielle, and F. Farzaneh
Expression of a Variant of CD28 on a Subpopulation of Human NK Cells: Implications for B7-Mediated Stimulation of NK Cells
J. Immunol., July 1, 1999; 163(1): 62 - 70.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. S. Miller, T. Cervenka, J. Lund, I. J. Okazaki, and J. Moss
Purine Metabolites Suppress Proliferation of Human NK Cells Through a Lineage-Specific Purine Receptor
J. Immunol., June 15, 1999; 162(12): 7376 - 7382.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
T. A. Fehniger, M. H. Shah, M. J. Turner, J. B. VanDeusen, S. P. Whitman, M. A. Cooper, K. Suzuki, M. Wechser, F. Goodsaid, and M. A. Caligiuri
Differential Cytokine and Chemokine Gene Expression by Human NK Cells Following Activation with IL-18 or IL-15 in Combination with IL-12: Implications for the Innate Immune Response
J. Immunol., April 15, 1999; 162(8): 4511 - 4520.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
M. Egashira, N. Kawamata, K. Sugimoto, T. Kaneko, and K. Oshimi
P-Glycoprotein Expression on Normal and Abnormally Expanded Natural Killer Cells and Inhibition of P-Glycoprotein Function by Cyclosporin A and Its Analogue, PSC833
Blood, January 15, 1999; 93(2): 599 - 606.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
L. F. Kastrukoff, N. G. Morgan, D. Zecchini, R. White, A. J. Petkau, J. Satoh, and D. W. Paty
Natural killer cells in relapsing-remitting MS: Effect of treatment with interferon {beta}-1B
Neurology, January 1, 1999; 52(2): 351 - 351.
[Abstract] [Full Text]

Home page
 BloodHome page
D. Rukavina, G. Laskarin, G. Rubesa, N. Strbo, I. Bedenicki, D. Manestar, M. Glavas, S. E. Christmas, and E. R. Podack
Age-Related Decline of Perforin Expression in Human Cytotoxic T Lymphocytes and Natural Killer Cells
Blood, October 1, 1998; 92(7): 2410 - 2420.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. Frey, N. B. Packianathan, T. A. Fehniger, M. E. Ross, W.-C. Wang, C. C. Stewart, M. A. Caligiuri, and S. S. Evans
Differential Expression and Function of L-Selectin on CD56bright and CD56dim Natural Killer Cell Subsets
J. Immunol., July 1, 1998; 161(1): 400 - 408.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. Tomura, X.-Y. Zhou, S. Maruo, H.-J. Ahn, T. Hamaoka, H. Okamura, K. Nakanishi, T. Tanimoto, M. Kurimoto, and H. Fujiwara
A Critical Role for IL-18 in the Proliferation and Activation of NK1.1+CD3- Cells
J. Immunol., May 15, 1998; 160(10): 4738 - 4746.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. D. Voss, J. Daley, J. Ritz, and M. J. Robertson
Participation of the CD94 Receptor Complex in Costimulation of Human Natural Killer Cells
J. Immunol., February 15, 1998; 160(4): 1618 - 1626.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
J. S. Miller, F. Prosper, and V. McCullar
Natural Killer (NK) Cells Are Functionally Abnormal and NK Cell Progenitors Are Diminished in Granulocyte Colony-Stimulating Factor-Mobilized Peripheral Blood Progenitor Cell Collections
Blood, October 15, 1997; 90(8): 3098 - 3105.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
A. Nagler, A. Ackerstein, R. Or, E. Naparstek, and S. Slavin
Immunotherapy With Recombinant Human Interleukin-2 and Recombinant Interferon-alpha in Lymphoma Patients Postautologous Marrow or Stem Cell Transplantation
Blood, June 1, 1997; 89(11): 3951 - 3959.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
Corrections for vol. 184, p. 1845
J. Exp. Med., March 17, 1997; 185(6): 1149 - 1150.
[Full Text] [PDF]

Home page
 ScienceHome page
R Giorda, W. Rudert, C Vavassori, W. Chambers, J. Hiserodt, and M Trucco
NKR-P1, a signal transduction molecule on natural killer cells
Science, September 14, 1990; 249(4974): 1298 - 1300.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1989 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1989 by The American Association of Immunologists, Inc. All rights reserved.